The global asthma & COPD therapies market was valued at $36.21bn in 2018 and is projected to grow to $60.8bn by 2030.

How this report will benefit you
  • Read on to discover how you can exploit the future business opportunities emerging in this sector.
  • In this brand new 177-page report you will receive 100 charts– all unavailable elsewhere.
  • The 177-page report provides clear detailed insight into the Top 26 asthma & COPD companies. Discover the key drivers and challenges affecting the market.
  • By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
Profiles of the leading 26 asthma & COPD companies:
  • Adamis Pharmaceuticals Corporation
  • Aerocrine (Circassia)
  • ALK-Abello A/S
  • Amphastar Pharmaceuticals, Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • Cipla
  • Dimerix
  • GlaxoSmithKline
  • Innoviva
  • Lallemand Pharma International
  • Merck
  • Mereo BioPharma Group plc
  • MundiPharma
  • Novartis
  • Pulmatrix
  • Respiratorius AB
  • Roche
  • Other companies
The content of each profile differs, depending on the organization. In general, a profile gives the following information:
  • An overview and analysis of the company
  • A portfolio of the company’s marketed product and product pipeline
  • Financial Information
  • Revenue forecast from 2020-2030
  • Recent developments
  • Future Outlook

Key questions answered by this report:
  • How is the Asthma & COPD Companies market evolving?
  • What is driving and restraining the Asthma & COPD Companies market?
  • What are the market shares of each segment of the overall Asthma & COPD Companies market in 2019?
  • What will be the main driver for the overall market from 2019 to 2030?
  • Will leading Asthma & COPD Companies broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?
  • How will the industry evolve during the period between 2019 and 2030?